Literature DB >> 2850277

The transmission potential of monkeypox virus in human populations.

P E Fine1, Z Jezek, B Grab, H Dixon.   

Abstract

Data on monkeypox in Zaire over the five years 1980-1984 are analysed to assess the protection imparted by past smallpox vaccination and the transmission potential of the virus in unvaccinated communities. Attack rates in individuals with and without vaccination scars indicated that smallpox vaccination (discontinued in 1980) imparted approximately 85% protection against monkeypox. It is predicted that monkeypox virus will continue to be introduced into human communities from animal sources, and that the average magnitude and duration of monkeypox epidemics will increase as vaccine-derived protection declines in the population. On the other hand, current evidence indicates that the virus is appreciably less transmissible than was smallpox, and that it will not persist in human communities, even in the total absence of vaccination. The findings thus support the recommendation of the Global Commission for the Certification of Smallpox Eradication to cease routine smallpox vaccination in monkeypox endemic areas, but to encourage continued epidemiological surveillance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850277     DOI: 10.1093/ije/17.3.643

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  78 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 3.  Whither monkeypox vaccination.

Authors:  Anne W Rimoin; Barney S Graham
Journal:  Vaccine       Date:  2011-12-19       Impact factor: 3.641

4.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

Review 5.  Epidemic dynamics at the human-animal interface.

Authors:  James O Lloyd-Smith; Dylan George; Kim M Pepin; Virginia E Pitzer; Juliet R C Pulliam; Andrew P Dobson; Peter J Hudson; Bryan T Grenfell
Journal:  Science       Date:  2009-12-04       Impact factor: 47.728

6.  Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.

Authors:  Erika Hammarlund; Anindya Dasgupta; Clemencia Pinilla; Patricia Norori; Klaus Früh; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

Review 7.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

8.  Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.

Authors:  William D Arndt; Samantha Cotsmire; Kelly Trainor; Heather Harrington; Kevin Hauns; Karen V Kibler; Trung P Huynh; Bertram L Jacobs
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

9.  Bayesian Monitoring of Emerging Infectious Diseases.

Authors:  Pavel Polyakov; Romulus Breban
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

10.  Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.

Authors:  Adam Macneil; Mary G Reynolds; Zach Braden; Darin S Carroll; Vanda Bostik; Kevin Karem; Scott K Smith; Whitni Davidson; Yu Li; Amba Moundeli; Jean-Vivien Mombouli; Aisha O Jumaan; D Scott Schmid; Russell L Regnery; Inger K Damon
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.